The TRAIL in the Treatment of Human Cancer: An Update on Clinical Trials.

导出 LinkOut

翻译打印收藏纠错

第一作者： Martin,Snajdauf

第一单位： Third Department of Surgery, First Faculty of Medicine, Charles University and University Hospital Motol, Prague, Czechia.

作者： Martin,Snajdauf ^[1] ; Klara,Havlova ^[2] ; Jiri,Vachtenheim ^[1] ; Andrej,Ozaniak ^[1] ; Robert,Lischke ^[1] ; Jirina,Bartunkova ^[3] ; Daniel,Smrz ^[3] ; Zuzana,Strizova ^[3]

作者单位： Third Department of Surgery, First Faculty of Medicine, Charles University and University Hospital Motol, Prague, Czechia. ^[1] Department of Urology, Second Faculty of Medicine, Charles University and University Hospital Motol, Prague, Czechia. ^[2] Department of Immunology, Second Faculty of Medicine, Charles University and University Hospital Motol, Prague, Czechia. ^[3]

关键词 TRAIL clinical trials TRAIL-receptor agonists cancer dulanermin mapatumumab recombinant TRAIL

DOI 10.3389/fmolb.2021.628332

PMID 33791337

发布时间 2021-04-02

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Frontiers in molecular biosciences

2021年8卷

628332页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

The TRAIL in the Treatment of Human Cancer: An Update on Clinical Trials.

Frontiers in molecular biosciences

相似文献

Frontiers in molecular biosciences

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

The TRAIL in the Treatment of Human Cancer: An Update on Clinical Trials.

Frontiers in molecular biosciences

相似文献

Frontiers in molecular biosciences

相关期刊

检索历史清除